drugset

drugset / Trial / NCT06430047

Efficacy and Safety of EsoDuo®

NCT06430047 ↗

Phase 4 Unknown 180 enrolled Chong Kun Dang Pharmaceutical

NaSingle-groupOpen-labelTreatment

Summary

Clinical Trial to Evaluate the Effects of EsoDuo® in Controlling Reflux Symptoms Related to the Acid

Timeline

Start: 2022-11-25
Primary completion: 2025-01
Completion: 2025-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	EsoDuo®	Unknown	—	Oral

Indications